AngioDynamics Stock Today

ANGO Stock  USD 13.00  0.14  1.09%   
Market Performance
0 of 100
Odds Of Distress
Less than 1
AngioDynamics is selling for 13.00 as of the 27th of January 2023. This is a 1.09 percent increase since the beginning of the trading day. The stock's open price was 12.86. AngioDynamics has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for AngioDynamics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2022 and ending today, the 27th of January 2023. Click here to learn more.
Fiscal Year End
Business Domain
Health Care Equipment & Services
IPO Date
27th of May 2004
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company has 39.13 M outstanding shares of which 1.45 M shares are presently shorted by private and institutional investors with about 2.76 trading days to cover. More on AngioDynamics

Moving against AngioDynamics

-0.6MSFTMicrosoft Aggressive PushPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

AngioDynamics Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AngioDynamics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AngioDynamics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO and President and DirectorJoseph DeVivo
Thematic IdeaCancer Fighters (view all)
Fama & French Classification
Average Analyst Recommendation
Analysts covering AngioDynamics report their recommendations after researching AngioDynamics' financial statements, talking to executives and customers, or listening in on AngioDynamics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering AngioDynamics. The AngioDynamics consensus assessment is calculated by taking the average forecast from all of the analysts covering AngioDynamics.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of AngioDynamics based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of AngioDynamics financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares Diluted32.9 M35.1 M
Notably Down
Slightly volatile
Weighted Average Shares32.8 M35.1 M
Notably Down
Slightly volatile
Return on Average Assets(5.63)(5.48)
Fairly Down
Slightly volatile
Net Cash Flow from Operations(8.5 M)(8.3 M)
Fairly Down
Slightly volatile
Current Liabilities59.7 M66.9 M
Fairly Down
Slightly volatile
Total Liabilities132.2 M115.4 M
Fairly Up
Slightly volatile
Gross Margin62.6960.27
Sufficiently Up
Slightly volatile
Total Debt23.1 M22.5 M
Fairly Up
Slightly volatile
Asset Turnover0.460.51
Moderately Down
Pretty Stable
Current Assets139 M129 M
Significantly Up
Very volatile
Total Assets541.5 M497.5 M
Significantly Up
Slightly volatile
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of AngioDynamics' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
Financial Strength
AngioDynamics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to AngioDynamics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand AngioDynamics' financial leverage. It provides some insight into what part of AngioDynamics' total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on AngioDynamics' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how AngioDynamics deploys its capital and how much of that capital is borrowed.
AngioDynamics cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 25 M in liabilities with Debt to Equity (D/E) ratio of 0.14, which may suggest the company is not taking enough advantage from borrowing. AngioDynamics has a current ratio of 2.23, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist AngioDynamics until it has trouble settling it off, either with new capital or with free cash flow. So, AngioDynamics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AngioDynamics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AngioDynamics to invest in growth at high rates of return. When we think about AngioDynamics' use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(8.49 Million)
AngioDynamics (ANGO) is traded on NASDAQ Exchange in USA and employs 760 people. AngioDynamics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 508.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AngioDynamics's market, we take the total number of its shares issued and multiply it by AngioDynamics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AngioDynamics conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 39.13 M outstanding shares of which 1.45 M shares are presently shorted by private and institutional investors with about 2.76 trading days to cover. AngioDynamics currently holds about 24.56 M in cash with (7.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
Check AngioDynamics Probability Of Bankruptcy
AngioDynamics holds a total of thirty-nine million one hundred thirty-four thousand one hundred outstanding shares. The majority of AngioDynamics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AngioDynamics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AngioDynamics. Please pay attention to any change in the institutional holdings of AngioDynamics as this could imply that something significant has changed or about to change at the company. Also note that nearly one million nine hundred fifty-six thousand seven hundred five invesors are currently shorting AngioDynamics expressing very little confidence in its future performance.

Ownership Allocation

Check AngioDynamics Ownership Details

AngioDynamics Stock Price Odds Analysis

Proceeding from a normal probability distribution, the odds of AngioDynamics jumping above the current price in 90 days from now is about 71.48%. The AngioDynamics probability density function shows the probability of AngioDynamics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days AngioDynamics has a beta of 0.6386. This suggests as returns on the market go up, AngioDynamics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding AngioDynamics will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. AngioDynamics is significantly underperforming NYSE Composite.
  Odds Below 13.0HorizonTargetOdds Above 13.0
28.33%90 days
Based on a normal probability distribution, the odds of AngioDynamics to move above the current price in 90 days from now is about 71.48 (This AngioDynamics probability density function shows the probability of AngioDynamics Stock to fall within a particular range of prices over 90 days) .

AngioDynamics Stock Institutional Holders

Institutional Holdings refers to the ownership stake in AngioDynamics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AngioDynamics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing AngioDynamics' value.
InstituionSecurity TypeTotal SharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K109 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K103 K
View AngioDynamics Diagnostics

AngioDynamics Historical Income Statement

AngioDynamics Income Statement is one of the three primary financial statements used for reporting AngioDynamics's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of AngioDynamics revenue and expense. AngioDynamics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
AngioDynamics Interest Expense is quite stable at the moment as compared to the past year. The company's current value of Interest Expense is estimated at 635,495. Operating Expenses is expected to rise to about 224.5 M this year, although the value of Direct Expenses will most likely fall to about 130.8 M. View More Fundamentals

AngioDynamics Stock Against Markets

Picking the right benchmark for AngioDynamics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AngioDynamics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AngioDynamics is critical whether you are bullish or bearish towards AngioDynamics at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in AngioDynamics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Ceiling Movement Now


Price Ceiling Movement

Calculate and plot Price Ceiling Movement for different equity instruments
All  Next Launch Module

AngioDynamics Corporate Directors

AngioDynamics corporate directors refer to members of an AngioDynamics board of directors. The board of directors generally takes responsibility for the AngioDynamics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AngioDynamics' board members must vote for the resolution. The AngioDynamics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Jeffrey Gold - Independent DirectorProfile
Steven Laporte - Independent DirectorProfile
Jan Reed - DirectorProfile
Dennis Meteny - Independent DirectorProfile

Invested in AngioDynamics?

The danger of trading AngioDynamics is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AngioDynamics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AngioDynamics. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AngioDynamics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
508.7 M
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine AngioDynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.